These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1879315)

  • 21. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental studies on the effects of Nd;YAG laser photocoagulation of arrhythmogenic foci].
    Nakano H
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Jun; 37(6):1105-13. PubMed ID: 2809283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease.
    Bode K; Hindricks G; Piorkowski C; Sommer P; Janousek J; Dagres N; Arya A
    Pacing Clin Electrophysiol; 2008 Dec; 31(12):1585-91. PubMed ID: 19067811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans.
    Pak HN; Hong SJ; Hwang GS; Lee HS; Park SW; Ahn JC; Moo Ro Y; Kim YH
    J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1357-63. PubMed ID: 15610278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term success of substrate-based mapping and ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia.
    Verma A; Kilicaslan F; Schweikert RA; Tomassoni G; Rossillo A; Marrouche NF; Ozduran V; Wazni OM; Elayi SC; Saenz LC; Minor S; Cummings JE; Burkhardt JD; Hao S; Beheiry S; Tchou PJ; Natale A
    Circulation; 2005 Jun; 111(24):3209-16. PubMed ID: 15956125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of two potentials for predicting successful catheter ablation from the left sinus of Valsalva for left ventricular epicardial tachycardia.
    Tada H; Naito S; Ito S; Kurosaki K; Ueda M; Shinbo G; Hoshizaki H; Oshima S; Taniguchi K; Nogami A
    Pacing Clin Electrophysiol; 2004 Aug; 27(8):1053-9. PubMed ID: 15305952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radiofrequency catheter ablation of ventricular tachycardia in patients without apparent structural cardiopathy].
    Peinado Peinado R; Arenal Maíz A; Almendral Garrote J; Pérez Villacastín J; Merino Llorens JL; Martínez-Alday JD; Pastor Fuentes A; Medina Moreno O; Valero Parra R; Delcán Domínguez JL
    Rev Esp Cardiol; 1994 Dec; 47(12):803-10. PubMed ID: 7855375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome.
    Doppalapudi H; Yamada T; McElderry HT; Plumb VJ; Epstein AE; Kay GN
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):23-9. PubMed ID: 19808390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.
    Marchlinski FE; Zado E; Dixit S; Gerstenfeld E; Callans DJ; Hsia H; Lin D; Nayak H; Russo A; Pulliam W
    Circulation; 2004 Oct; 110(16):2293-8. PubMed ID: 15477406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microwave ablation of canine atrial tachycardia induced by aconitine.
    Rho TH; Ito M; Pride HP; Waller B; Zipes DP
    Am Heart J; 1995 May; 129(5):1021-5. PubMed ID: 7732960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action potential duration restitution and ventricular fibrillation due to rapid focal excitation.
    Swissa M; Qu Z; Ohara T; Lee MH; Lin SF; Garfinkel A; Karagueuzian HS; Weiss JN; Chen PS
    Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1915-23. PubMed ID: 11959659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nd:YAG laser-photocoagulation: acute electrophysiological, hemodynamic, and morphological effects in large irradiated areas.
    Wietholt D; Alberty J; Hindricks G; Vogt B; Haverkamp W; Blasius S; Gülker H; Breithardt G
    Pacing Clin Electrophysiol; 1992 Jan; 15(1):52-9. PubMed ID: 1371001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neodymium:YAG laser photocoagulation: a successful new map-guided technique for the intraoperative ablation of ventricular tachycardia.
    Svenson RH; Gallagher JJ; Selle JG; Zimmern SH; Fedor JM; Robicsek F
    Circulation; 1987 Dec; 76(6):1319-28. PubMed ID: 3677355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced electrophysiological isolation of the myocardium prevents ventricular fibrillation.
    Moulopoulos SD; Sideris DA; Toumanidis ST; Karagiannis DP; Kostis EB; Kontogiannis AB; Kitsiou AN; Deligeorgi-Politi H
    Acta Cardiol; 1991; 46(6):621-30. PubMed ID: 1792834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lithium on time to onset of aconitine-induced initial arrhythmia and ventricular tachycardia.
    Oredipe OA; Stohs SJ
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):249-56. PubMed ID: 508007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracoronary ethyl alcohol or phenol injection ablates aconitine-induced ventricular tachycardia in dogs.
    Inoue H; Waller BF; Zipes DP
    J Am Coll Cardiol; 1987 Dec; 10(6):1342-9. PubMed ID: 3680803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Site of the arrhythmogenic focus and cardiac vulnerability to ventricular fibrillation.
    Murakawa Y; Yamashita T; Ajiki K; Hayami N; Fukui E; Kasaoka Y; Omata M; Nagai R
    Pacing Clin Electrophysiol; 2002 Apr; 25(4 Pt 1):446-56. PubMed ID: 11991370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between laser and electrical ablation of ventricle in dogs: hemodynamic, pathologic and electrocardiographic observations.
    Wu TG; Lu ZY
    J Tongji Med Univ; 1992; 12(4):237-42. PubMed ID: 1289573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of SK&F 93479 on experimentally induced ventricular arrhythmias in dogs, rats and mice.
    Dai S
    Agents Actions; 1984 Oct; 15(3-4):131-6. PubMed ID: 6151803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.